FY 22 nfrp services

Ended Awarded Last action

Contract number
W81XWH22F0274
Awardee
Awarding agency
Obligated
$228,592

Award facts

Opportunity
  • W81XWH17R0036 Solicitation number
Contract value 100% obligated
$228,592.02 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Two Step
Pricing
Cost Plus Fixed Fee
Place of performance
Frederick, MD 21702, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00002 · FY 22 neurofibromatosis research program (nfrp) services $13,669
Supplemental Agreement for work within scope P00001 · FY 22 neurofibromatosis research program (nfrp) meeting, scientific, and support services (mpass) $27,458
Original award $187,465

About this award

The Defense Health Agency issued a delivery order to Leidos, Inc. on August 28, 2022, with a ceiling value of $228,592.02 and an ultimate completion date of August 28, 2023, for FY 2022 Neurofibromatosis Research Program services.

Place of performance is Frederick, MD. The order is priced on a cost-plus-fixed-fee basis and carries no set-aside designation.

Quick answers

Who was awarded contract W81XWH22F0274?

W81XWH22F0274 was awarded to Leidos, Inc. by Defense Health Agency (Department of Defense) on August 28, 2022.

How much is contract W81XWH22F0274 worth?

The government has obligated $228,592 on W81XWH22F0274.

Is contract W81XWH22F0274 an order under another contract?

Yes. W81XWH22F0274 is a delivery order under W81XWH17D0025, an indefinite delivery contract.

Was contract W81XWH22F0274 competed?

The extent of competition for W81XWH22F0274 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award